Has Carlene Springer, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $11,859 in general payments to Carlene Springer, APRN across 604 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carlene Springer, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carlene Springer, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carlene Springer, APRN

Family · Hastings, NENPI 1669875803

Payments from drug & device makers

$11,859in general payments, 2019–2025

Across 604 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$979
Eisai Inc.$956
Seagen Inc.$686
Pfizer$620
Merck$596
Daiichi Sankyo Inc.$584
plus $7K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	54	$979
Eisai Inc.	24	$956
Seagen Inc.	26	$686
Pfizer	36	$620
Merck	33	$596
Daiichi Sankyo Inc.	38	$584
AstraZeneca(2 entities)	24	$472
Lilly USA, LLC	24	$453
Pharmacyclics LLC, An Abbvie Company	20	$390
Johnson & Johnson	23	$390
Amgen	30	$371
Sanofi-aventis U.S. LLC	4	$356
E.r. Squibb & Sons, L.L.C.	20	$343
Astellas Pharma US Inc	11	$342
Gilead(2 entities)	16	$338
AbbVie	17	$332
Incyte Corporation	15	$275
Sanofi	15	$239
Bristol Myers Squibb	13	$227
Karyopharm Therapeutics Inc.	13	$216
Adaptive Biotechnologies Corporation	13	$212
Servier Pharmaceuticals LLC	10	$194
Exelixis Inc.	5	$164
Regeneron Healthcare Solutions, Inc.	10	$160
Takeda Pharmaceuticals U.S.A., Inc.	9	$157
Tersera Therapeutics LLC	6	$138
Genentech USA, Inc.	9	$137
Recordati_rare_diseases_inc.	3	$124
Jazz Pharmaceuticals Inc.	7	$124
Octapharma USA, Inc.	5	$117
GSK	7	$110
Ipsen Biopharmaceuticals, Inc	4	$96
Bayer	5	$90
Taiho Oncology, Inc.	5	$86
Pharmaessentia USA Corporation	5	$85
Array Biopharma Inc	6	$84
Syndax Pharmaceuticals, Inc.	4	$72
Mirati Therapeutics, Inc.	4	$70
Stemline Therapeutics Inc.	3	$52
Foundation Medicine, Inc.	3	$50
Tolmar Pharmaceuticals, Inc.	2	$32
Pharmaand GmbH	2	$29
Tolmar, Inc.	2	$29
Sobi, Inc	1	$25
Rigel Pharmaceuticals, Inc.	2	$23
Deciphera Pharmaceuticals Inc.	1	$19
Novocure Inc.	1	$19
Aimmune Therapeutics, Inc.	1	$19
Clovis Oncology, Inc.	1	$17
CTI Biopharma Corp.	1	$16
G1 Therapeutics, Inc.	1	$15
Blueprint Medicines Corporation	1	$15
Puma Biotechnology, Inc.	1	$15
Fennec Pharmaceuticals, Inc.	1	$14
Medtronic	1	$13
AMAG Pharmaceuticals, Inc.	1	$13
Blue Earth Diagnostics	1	$13
Boehringer Ingelheim	1	$13
Myriad Genetic Laboratories, Inc.	1	$12
Morphosys, US Inc.	1	$12

How this compares

$11,859 in reported general payments places this provider in the 95th percentile of 809 family providers in Nebraska.

See all family providers in Nebraska →

Medicare billing

Part B allowed, 2024

$72,393

Medicare patients

311

Services billed

1,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Hastings

Leslie KathmanHastings$7K
Tamaka GangwishHastings$4K
Gwendolyn JourneyHastings$4K
Brenda NunleyHastings$4K
Chantel CollierFriend$257K
Stephanie SimonOmaha$157K
Rebecca NewberryOmaha$156K
Michelle BrtekzwienerNorfolk$59K
Angela CraigOmaha$35K
Laura FalconeOmaha$26K

See the full list for Nebraska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →